HomeAKBA • NASDAQ
Akebia Therapeutics Inc
add
$3.04
2.25%
Pre-market:(0.33%)-0.0100
$3.03
Closed: Aug 20, 6:00:20 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 62.47M | 43.13% |
Operating expense | 37.57M | -13.79% |
Net income | 247.00K | 102.88% |
Net profit margin | 0.40 | 102.03% |
Earnings per share | 0.03 | 166.75% |
EBITDA | 14.51M | 1,124.05% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 137.31M | 247.62% |
Total assets | 345.60M | 56.95% |
Total liabilities | 316.37M | 24.58% |
Total equity | 29.22M | — |
Shares outstanding | 265.15M | — |
Price to book | 28.27 | — |
Return on assets | 10.82% | — |
Return on capital | 15.93% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 247.00K | 102.88% |
Cash from operations | 22.35M | 321.98% |
Cash from investing | -126.00K | -334.48% |
Cash from financing | 1.72M | -77.49% |
Net change in cash | 23.94M | 1,075.11% |
Free cash flow | 23.77M | -46.03% |
Previous close
$3.11
Day range
$3.02 - $3.15
Year range
$1.24 - $4.08
Market cap
806.04M USD
Avg Volume
3.71M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
181
